New Firm Aims to Transform Trial Startup
CliniStart announced the company’s opening as a new services provider with specialty focus in clinical trial startup functions, specifically focused in the niche area of clinical trial contracting. The company manages all aspects of the clinical trial contract development and negotiations life cycle, as well as investigator grant budget processes with exceptional knowledge and skill.
Sam Searcy, CEO and key founder of CliniStart, previously cofounded Clintrax Global and served as a global contracting account leader for strategic partnerships with large pharma sponsors. “We believe that in the near future, CliniStart will be the preferred partner for clinical trial contract negotiations and investigator grant budget development for both pharmaceutical sponsors and industry CROs. Our services and software solutions will allow sponsors and CROs to focus on the crucial work of managing clinical trials.”
For more information, click here.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Phase III PROMINENT Trial Initiated to Evaluate Felzartamab for Primary Membranous Nephropathy
June 30th 2025The global Phase III PROMINENT trial has begun dosing patients to evaluate felzartamab in treating primary membranous nephropathy, a serious autoimmune kidney disorder with no FDA-approved therapies.
